News

Filter

Current filters:

VyvanseResearch

Shire agrees to FDA call for pediatric trials of Vyvanse for ADHD

Shire agrees to FDA call for pediatric trials of Vyvanse for ADHD

12-06-2014

Ireland-headquartered drugmaker Shire says it has agreed to a written request by the US Food and Drug…

NeurologicalPharmaceuticalRegulationResearchShireUSAVyvanse

Shire will drop MDD indication for Vyvanse after failed endpoints in Ph III

07-02-2014

Shares of Ireland-headquartered Shire fell 2.4% to £30.67 in early trading, after the company presented…

NeurologicalPharmaceuticalResearchShireVyvanse

Shire demonstrates efficacy of ADHD drug for binge eating

05-11-2013

Shire has announced top-line results from two identically designed randomized placebo-controlled Phase…

EuropePharmaceuticalRare diseasesResearchShireVyvanse

Efficacy of Shire's Vyvanse maintained in ADHD adolescents after at least six months

24-05-2012

A significantly lower proportion of subjects experiencing treatment failure whilst receiving UK specialty…

NeurologicalPharmaceuticalResearchShireVyvanse

COMPANY SPOTLIGHT

Menarini

Back to top